Covered recipient · General Payments record
HENRY A TRAN
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$2,548.60
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $281.21 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $96.42 | 1 |
| ABBVIE INC. | $55.49 | 2 |
| Lilly USA, LLC | $36.83 | 2 |
| PFIZER INC. | $21.74 | 1 |
| Genentech USA, Inc. | $19.02 | 1 |
| Biogen, Inc. | $18.21 | 1 |
| Teva Pharmaceuticals USA, Inc. | $17.20 | 1 |
| Lundbeck LLC | $16.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.67 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106238504 | CMS |
| ABBVIE INC. | $22.82 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106238506 | CMS |
| Biogen, Inc. | $18.21 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104815807 | CMS |
| E.R. Squibb & Sons, L.L.C. | $96.42 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101430673 | CMS |
| Genentech USA, Inc. | $19.02 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133020502 | CMS |
| Lilly USA, LLC | $21.43 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134999708 | CMS |
| Lilly USA, LLC | $15.40 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135018938 | CMS |
| Lundbeck LLC | $16.30 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145976169 | CMS |
| PFIZER INC. | $21.74 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131519308 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.20 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151568819 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.